Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.39.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.233NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.320NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.635NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.19 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.15 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.113NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.88NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.98.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.34.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.124.1.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.203NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.8.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.7.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.254NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.36.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.122.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.79 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.209NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.236NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.395NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.120.2.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.416.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.532NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-16341.6US
B.1.408NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XHNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.168NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AH.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used